#TCMD

Lead report

Tactile Medical projects $360M-$366M 2026 revenue as airway clearance ordering normalizes in Q4 (NASDAQ:TCMD)

TCMD Q2 2026 earnings call recap: raised revenue guidance to $360–$366M, lymphedema strength, AffloVest inventory reset, Medicare prior auth impact—read...